III Capital Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Buy
100,684
+3,525
+4% +$112K 0.73% 21
2026
Q1
$3.06M Sell
97,159
-87,973
-48% -$2.77M 0.89% 16
2025
Q4
$5.45M Buy
185,132
+25,000
+16% +$695K 0.8% 12
2025
Q3
$4.04M Buy
160,132
+48,102
+43% +$1.17M 0.97% 13
2025
Q2
$2.69M Sell
112,030
-45,000
-29% -$1.04M 0.48% 23
2025
Q1
$3.6M Sell
157,030
-35,000
-18% -$845K 0.65% 20
2024
Q4
$4.86M Sell
192,030
-8,985
-4% -$228K 0.78% 17
2024
Q3
$5.01M Buy
201,015
+64,580
+47% +$1.91M 0.37% 34
2024
Q2
$4.05M Buy
136,435
+50,458
+59% +$1.4M 0.19% 57
2024
Q1
$2.59M Buy
+85,977
New +$2.39M 0.12% 74

Other funds holding RTO

III Capital Management's RTO Position: Q2 2026 in Review

III Capital Management increased its Rentokil (RTO) stake by 3.6% in Q2 2026, buying an estimated $112K and bringing the position to 100,684 shares worth $2.88M. The position accounts for 0.73% of the portfolio, ranked #21.

III Capital Management first reported a position in RTO in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.45M in Q4 2025. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • III Capital Management held 100,684 shares of Rentokil worth $2.88M as of Q2 2026.
  • III Capital Management bought 3,525 Rentokil shares in Q2 2026, an estimated $112K.
  • Rentokil made up 0.73% of III Capital Management's portfolio in Q2 2026, its #21 holding.
  • III Capital Management first reported a position in Rentokil in Q1 2024 and has held it in 10 quarters since.
  • III Capital Management's Rentokil position peaked at $5.45M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on III Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.